Topics: COVID-19
News
-
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ARCS Webinar Series: COVID-19: considerations and strategies for running trials during the pandemic
-
ClinTrial Refer COVID-19 app access
-
JAMA recommendations on maintaining clinical trial integrity during COVID-19 pandemic
-
ACTA statement on COVID-19
-
NSW Health COVID-19 Research Grants
-
Symposium: Social and ethical implications of the COVID-19 pandemic
-
COVID-19: Guidance on Australian clinical trials for institutions, HRECs, researchers and sponsors
-
NHMRC seeks experts to assess COVID-19 grant applications
-
Survey: Cochrane COVID-19 Core Outcome Set Project
-
The Lancet COVID-19 Resource Centre
-
Tweetchats with PRAXIS and ACTA
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
MHRA guidance on managing clinical trials during Coronavirus (COVID19)
-
Australian Research Council extensions due to COVID-19 impact on researchers
-
The US Food and Drug Administration (FDA) guidance on conduct of clinical trials of medical products during COVID-19 pandemic was updated 27 March 2020
-
COVID-19 and clinical trial updates
-
Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry